Compound ID | 2222
Class: Small molecule antibacterial agent
| Spectrum of activity: | Gram-positive & Gram-negative |
| Details of activity: | Active against ESKAPE pathogens including arm, erm-, cfr- and lsaA-expressing strains; binds to the large ribosomal subunit interfering with translation initiation |
| Description: | Synthetic compound (component based and structure guided design; contains oxepanoprolinamide core); non-haemolytic and non-toxic towards mammalian cell; bacteriostatic |
| Year first mentioned: | 2021 |
| Development status: | Experimental |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/162366972 |
| Guide to Pharmacology: | iboxamycin |
| Citations: |
|